Aura Biosciences Statistics
Share Statistics
Aura Biosciences has 50.27M
shares outstanding. The number of shares has increased by 1.38%
in one year.
Shares Outstanding | 50.27M |
Shares Change (YoY) | 1.38% |
Shares Change (QoQ) | 0.55% |
Owned by Institutions (%) | 79.43% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 7,768 |
FTD / Avg. Volume | 2.94% |
Short Selling Information
The latest short interest is 1.95M, so 3.89% of the outstanding
shares have been sold short.
Short Interest | 1.95M |
Short % of Shares Out | 3.89% |
Short % of Float | 5.26% |
Short Ratio (days to cover) | 5.86 |
Valuation Ratios
The PE ratio is -4.7 and the forward
PE ratio is -2.62.
Aura Biosciences's PEG ratio is
0.5.
PE Ratio | -4.7 |
Forward PE | -2.62 |
PS Ratio | 0 |
Forward PS | 1.6 |
PB Ratio | 2.69 |
P/FCF Ratio | -5.03 |
PEG Ratio | 0.5 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aura Biosciences.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.77,
with a Debt / Equity ratio of 0.12.
Current Ratio | 10.77 |
Quick Ratio | 10.77 |
Debt / Equity | 0.12 |
Debt / EBITDA | -0.22 |
Debt / FCF | -0.23 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-819,990.57 |
Employee Count | 106 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 112K |
Effective Tax Rate | -0.13% |
Stock Price Statistics
The stock price has increased by -21.88% in the
last 52 weeks. The beta is 0.43, so Aura Biosciences's
price volatility has been higher than the market average.
Beta | 0.43 |
52-Week Price Change | -21.88% |
50-Day Moving Average | 6.47 |
200-Day Moving Average | 8.25 |
Relative Strength Index (RSI) | 53.99 |
Average Volume (20 Days) | 264,380 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -96.12M |
Net Income | -86.92M |
EBITDA | -85.58M |
EBIT | n/a |
Earnings Per Share (EPS) | -1.75 |
Full Income Statement Balance Sheet
The company has 31.69M in cash and 18.77M in
debt, giving a net cash position of 12.92M.
Cash & Cash Equivalents | 31.69M |
Total Debt | 18.77M |
Net Cash | 12.92M |
Retained Earnings | -374.23M |
Total Assets | 182.5M |
Working Capital | 145.71M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -79.81M
and capital expenditures -1.25M, giving a free cash flow of -81.06M.
Operating Cash Flow | -79.81M |
Capital Expenditures | -1.25M |
Free Cash Flow | -81.06M |
FCF Per Share | -1.63 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |